RESEARCH-USE BIOSIMILAR ANTIBODY
Sifalimumab
Monoclonal antibody · IgG1
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research.
TARGETIFNA1
YMonoclonal antibody
CATALOGSC-BS-180
CATALOG NUMBERSC-BS-180
MOLECULAR WEIGHTApprox. 144.24 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research.
Sifalimumab is a recombinant research-use antibody directed against IFNA1.